M. Douglas Baumann - Concepedia

Author

M. Douglas Baumann

University of Toronto

Also Known As

M. Douglas Baumann, M.D. Baumann

Publications

779

Citations

H-Index

Concepts

All Affiliations

University of Toronto Canada Research Chairs Toronto Western Hospital

About

M. Douglas Baumann is an author at University of Toronto specializing in biomedical engineering, medicine, and spinal cord injury.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	558
2	Biomedical Engineering	5	5	613
3	Engineering	4	4	602
4	Immunology	1	1	11
5	Neurology	1	1	108

M. Douglas Baumann

Publications

725

Citations

H-Index

Page 1

	Year	Citations
An injectable drug delivery platform for sustained combination therapy M. Douglas Baumann, Catherine E. Kang, Jason C. Stanwick, Journal of Controlled Release NanomedicineTranslational MedicineEngineeringMedicineTargeted Drug Delivery	2009	206
Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury M. Douglas Baumann, Catherine E. Kang, Charles H. Tator, Biomaterials HydrogelsSpinal Cord InjuryEngineeringSpinal TraumaIntrathecal Delivery	2010	189
The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditis James W. Austin, Catherine E. Kang, M. Douglas Baumann, Biomaterials Tissue EngineeringInflammationIntrathecal InjectionHyaluronan-based HydrogelSpinal Cord Injury	2012	108
Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel Jason C. Stanwick, M. Douglas Baumann, Molly S. Shoichet Journal of Controlled Release Tissue EngineeringHydrogelsBiopolymer GelBiofunctional MaterialNanoparticle-loaded Composite Hydrogel	2012	99
Localized and Sustained Delivery of Fibroblast Growth Factor-2 from a Nanoparticle-Hydrogel Composite for Treatment of Spinal Cord Injury Catherine E. Kang, M. Douglas Baumann, Charles H. Tator, Cells Tissues Organs	2012	68
In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury Jason C. Stanwick, M. Douglas Baumann, Molly S. Shoichet International Journal of Pharmaceutics Regenerative MedicineNeuroregenerationSpinal Cord InjuryMedicineSpinal Trauma	2012	44
A quantitative ELISA for bioactive anti-Nogo-A, a promising regenerative molecule for spinal cord injury repair M. Douglas Baumann, James W. Austin, Michael G. Fehlings, Methods Regenerative MedicineTranslational MedicineNeuroregenerationSpinal Cord InjuryPromising Regenerative Molecule	2008	11

Page 1